Unraveling Metabolic Reprogramming in Cancer with Spatial Proteomics
Modular Imaging Mass Cytometry panels identify metabolic states of tumor and immune cells in the tissue microenvironment.
Read App Note
Detecting and Quantifying Pathogens in an Environmental Setting with Genomic Tools that Scale
Read case studies featuring high-throughput qPCR applications for wastewater surveillance and antibiotic resistance tracking to learn how the Biomark™ X9 System for High-Throughput Genomics overcomes the limitations of conventional testing methods.
Read App Note
Viral Pathogen Detection with Custom Assays Using the 48.48 Dynamic Array IFC-X and the Biomark X9 System
This technical note demonstrates how we used a custom assay panel with the 48.48 Dynamic Array™ IFC-X (integrated fluidic circuit) to detect and differentiate influenza, RSV, SARS-CoV-2, coronaviruses, enteroviruses and more with high specificity, no cross-reactivity and minimal reagent use.
Read App Note
Download and read the latest whitepapers
The Tumor Microenvironment: A Complex Ecosystem
The tumor microenvironment (TME) is no longer considered a passive backdrop to cancer. It is a dynamic ecosystem that plays a central role in tumor growth, immune suppression, metastasis and treatment resistance.
Emerging Insights into Neurodegeneration: A Proteomic Perspective
Neurodegenerative disorders such as Alzheimer’s, Parkinson’s and multiple sclerosis are on the rise, with cases projected to double in the next 20 years.
Blood-Based Biomarkers for Neurological Disorders
Neurological disorders remain among the most pressing challenges in medicine, often requiring early and ongoing detection to improve outcomes.
